Citation: Ll. Hoey et al., LORAZEPAM STABILITY IN PARENTERAL SOLUTIONS FOR CONTINUOUS INTRAVENOUS ADMINISTRATION, The Annals of pharmacotherapy, 30(4), 1996, pp. 343-346
Citation: Sj. Tschida et al., THE IMPACT OF PRACTICE GUIDELINES ON PRESCRIBING PATTERNS OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS, Pharmacotherapy, 16(5), 1996, pp. 899-904
Authors:
TSCHIDA SJ
GUAY DRP
STRAKA RJ
HOEY LL
JOHANNING R
VANCEBRYAN K
Citation: Sj. Tschida et al., QT(C)-INTERVAL PROLONGATION ASSOCIATED WITH SLOW INTRAVENOUS ERYTHROMYCIN LACTOBIONATE INFUSIONS IN CRITICALLY ILL PATIENTS - A PROSPECTIVEEVALUATION AND REVIEW OF THE LITERATURE, Pharmacotherapy, 16(4), 1996, pp. 663-674
Citation: Sj. Tschida et al., COST-EFFECTIVE TREATMENT OF ATRACURIUM RESISTANCE IN CRITICALLY ILL PATIENTS, American journal of health-system pharmacy, 52(16), 1995, pp. 1818-1819
Authors:
JOHANNING RJ
ZASKE DE
TSCHIDA SJ
JOHNSON SV
HOEY LL
VANCEBRYAN K
Citation: Rj. Johanning et al., A RETROSPECTIVE STUDY OF SODIUM-NITROPRUSSIDE USE AND ASSESSMENT OF THE POTENTIAL RISK OF CYANIDE POISONING, Pharmacotherapy, 15(6), 1995, pp. 773-777
Citation: Sv. Johnson et al., INAPPROPRIATE VANCOMYCIN PRESCRIBING BASED ON CRITERIA FROM THE CENTERS-FOR-DISEASE-CONTROL AND PREVENTION, Pharmacotherapy, 15(5), 1995, pp. 579-585
Citation: Sj. Tschida et al., INCONSISTENCY WITH TRAIN-OF-4 MONITORING IN A CRITICALLY ILL PARALYZED PATIENT, Pharmacotherapy, 15(4), 1995, pp. 540-545
Citation: Cl. Solberg et al., CONTINUOUS INTRAVENOUS INFUSIONS OF LORAZEPAM VERSUS MIDAZOLAM FOR SEDATION, Critical care medicine, 23(8), 1995, pp. 1448-1449
Citation: Ll. Hoey et al., A RETROSPECTIVE REVIEW AND ASSESSMENT OF BENZODIAZEPINES IN THE TREATMENT OF ALCOHOL-WITHDRAWAL IN HOSPITALIZED-PATIENTS, Pharmacotherapy, 14(5), 1994, pp. 572-578
Citation: Ll. Hoey et al., A PROSPECTIVE EVALUATION OF BENZODIAZEPINE GUIDELINES IN THE MANAGEMENT OF PATIENTS HOSPITALIZED FOR ALCOHOL-WITHDRAWAL, Pharmacotherapy, 14(5), 1994, pp. 579-585
Citation: K. Vancebryan et al., ALTERNATIVE VIEWS ON THE EFFECTS OF RECOMBINANT INTERLEUKIN-1-RECEPTOR ANTAGONIST, American journal of hospital pharmacy, 51(21), 1994, pp. 2724-2725